Illustrative image – not actual.Biocon, a biotechnology firm, is likely to infuse $161 million (approx 716.45 crore) in Malaysian biotechnology Corporation SdnBhd (BiotechCorp).
The funds will be pumped in towards establishment of a bio-manufacturing and R&D facility in Bio-XCell, a custom-built biotechnology park and ecosystem in Iskandar Malaysia, Johor.
